STOCK TITAN

Insider selling 1,405,000 ATRA shares (NASDAQ: ATRA)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

ATRA reported a proposed sale of 1,405,000 shares of Common Stock via a Form 144. The filing states the shares were purchased in multiple open‑market transactions from January 2025 through August 2025 and in a registered direct financing in May 2025, with planned brokerage transactions on 08/15/2025.

Positive

  • None.

Negative

  • None.
Shares proposed for sale 1,405,000 shares listed under Securities To Be Sold
Planned sale date 08/15/2025 scheduled brokerage transactions date
Acquisition period January–August 2025 purchased in multiple open market transactions
Registered direct financing May 2025 one source of the purchased shares
Form 144 regulatory
"Securities To Be Sold | Common Stock | 08/15/2025"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
registered direct financing financial
"purchased in multiple open market transactions from January 2025 through August 2025 as well as a registered direct financing in May 2025"
A registered direct financing is when a company sells newly registered securities directly to a limited number of investors under an existing registration, skipping the broad public marketing of a typical offering; think of it as putting approved items on a store shelf and arranging a private sale to select buyers. Investors care because it can quickly raise cash while creating new shares or debt that may dilute existing ownership, affect the share price and change the company’s financial runway.
brokerage transactions market
"The Common Stock was purchased ... | Brokerage transactions"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the ATRA Form 144 report say was filed?

It reports a proposed sale of 1,405,000 shares of Common Stock. The filing notes purchases occurred January–August 2025 and a registered direct financing in May 2025, with brokerage transactions listed for 08/15/2025.

When were the shares reported to have been acquired for ATRA?

The shares were acquired between January 2025 and August 2025. The filing specifies multiple open‑market purchases during that period and a registered direct financing that closed in May 2025.

How many ATRA shares are proposed for sale in the Form 144?

The Form 144 lists 1,405,000 shares proposed for sale. The planned method of sale is via brokerage transactions with the listed sale date of 08/15/2025.

What sale method does the ATRA Form 144 indicate?

Brokerage transactions are listed as the method of sale. The filing identifies planned brokerage transactions and records cash as the consideration for the listed sale amount on 08/15/2025.

Does the Form 144 show any lockup or resale restrictions for ATRA shares?

The provided excerpt does not state specific lockup or resale restrictions. It only lists acquisition sources (open market and a registered direct financing) and the intended brokerage sale method on 08/15/2025.